About
Relay Therapeutics Inc (NASDAQ:RLAY) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
Apr 2 2026
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Mar 16 2026
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Feb 26 2026
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Feb 23 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Financials
Revenue
$15.36 M
Market Cap
$2.23 B
EPS
-1.61
Translate